- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.14 | 1.95 |
NAV | ₹29.82 | ₹417.41 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1208.05 Cr | ₹3416.13 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.14
1.95
NAV
₹29.82
₹417.41
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1208.05 Cr
₹3416.13 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 38.56% | 43.05% |
3 Year | 20.56% | 24.32% |
5 Year | 26.40% | 28.73% |
1 Year
38.56%
43.05%
3 Year
20.56%
24.32%
5 Year
26.40%
28.73%
Holding Analysis
Equity | 94.61% | 96.73% |
Cash | 5.39% | 3.27% |
Equity
94.61%
96.73%
Cash
5.39%
3.27%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.31% |
Aurobindo Pharma Ltd. | 8.57% |
Lupin Ltd. | 7.43% |
Dr. Reddy's Laboratories Ltd. | 6.48% |
Cipla Ltd. | 6.29% |
Divi's Laboratories Ltd. | 5.12% |
Fortis Healthcare Ltd. | 4.42% |
Zydus Lifesciences Ltd. | 3.91% |
Alkem Laboratories Ltd. | 3.60% |
Apollo Hospitals Enterprise Ltd. | 3.42% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.99% |
Max Healthcare Institute Ltd. | 6.26% |
Divi's Laboratories Ltd. | 6.21% |
Poly Medicure Ltd. | 5.38% |
Lupin Ltd. | 5.12% |
Lonza Group Ag | 4.55% |
Cipla Ltd. | 4.54% |
Krishna Institute of Medical Sciences Ltd | 3.99% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Mankind Pharma Ltd. | 3.51% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 09 Nov 2018 | 27 Jun 2011 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
09 Nov 2018
27 Jun 2011
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
